Bladder Cancer - Reported From The Annual Meeting Of The American Urological Association

ORLANDO, FL (UroToday.com) - Abstract 1791 showed the importance of a repeat TURBT for T1 grade 3 tumors. If there is no residual tumor (NRT) on the repeat TURBT patients do much better than if there is residual tumor (SRT). NRT - Recurrence 17% - Progression 10% - DFS 78% SRT - Recurrence 45% - Progression 23% - DFS 50% Abstract 1695 showed that 60% of all bladder cancer deaths occur within the first 2 years of diagnosis.

More: continued here

Filed under: Cancer on July 5th, 2008